← Find more feeds

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 333 followers

Latest posts

Last updated 1 day ago

Withdrawn application: DuoResp Spiromax, 27/04/2026

1 day ago

Withdrawn application: DuoResp Spiromax, 27/04/2026

Read full

Guideline on data requirements for authorisation of immunological veterinary medicinal products in exceptional circumstances - Scientific guideline

1 day ago

Guideline on data requirements for authorisation of immunological veterinary medicinal products in...

Read full

Withdrawn application: BiResp Spiromax, 27/07/2026

1 day ago

Withdrawn application: BiResp Spiromax, 27/07/2026

Read full

HMA-EMA Network Data Steering Group: membership list

1 day ago

HMA-EMA Network Data Steering Group: membership list

Read full

Step-by-step guide : Support with workload management in the authority workspace - CTIS Training Programme - Module 04

1 day ago

Step-by-step guide : Support with workload management in the authority workspace -...

Read full

Clinical Trial Information System (CTIS) - Sponsor handbook

1 day ago

Clinical Trial Information System (CTIS) - Sponsor handbook

Read full

FAQs: Support with workload management by workspace - CTIS Training Programme - Module 04

1 day ago

FAQs: Support with workload management by workspace - CTIS Training Programme -...

Read full

Referral: Tavneos, avacopan Article 20 procedures CHMP opinion, 25/06/2026, 26/06/2026

1 day ago

Referral: Tavneos, avacopan Article 20 procedures CHMP opinion, 25/06/2026, 26/06/2026

Read full

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 20, Status: Authorised

1 day ago

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation...

Read full

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2026

1 day ago

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)...

Read full

Human medicines European public assessment report (EPAR): Nylaspeg, pegfilgrastim, Status: Opinion

1 day ago

Human medicines European public assessment report (EPAR): Nylaspeg, pegfilgrastim, Status: Opinion

Read full

Human medicines European public assessment report (EPAR): Yartemlea, Narsoplimab, Status: Opinion

1 day ago

Human medicines European public assessment report (EPAR): Yartemlea, Narsoplimab, Status: Opinion

Read full

Or log in

Everything you care about in one place

What's new

Latest posts

Withdrawn application: DuoResp Spiromax, 27/04/2026

Guideline on data requirements for authorisation of immunological veterinary medicinal products in exceptional circumstances - Scientific guideline

Withdrawn application: BiResp Spiromax, 27/07/2026

HMA-EMA Network Data Steering Group: membership list

Step-by-step guide : Support with workload management in the authority workspace - CTIS Training Programme - Module 04

Clinical Trial Information System (CTIS) - Sponsor handbook

FAQs: Support with workload management by workspace - CTIS Training Programme - Module 04

Referral: Tavneos, avacopan Article 20 procedures CHMP opinion, 25/06/2026, 26/06/2026

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 20, Status: Authorised

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2026

Human medicines European public assessment report (EPAR): Nylaspeg, pegfilgrastim, Status: Opinion

Human medicines European public assessment report (EPAR): Yartemlea, Narsoplimab, Status: Opinion

Try Feeder for free